OTCMKTS:BAYRY - Bayer Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 13
  • Breakdown:
  • 1 Sell Ratings
  • 7 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
$11.98
▲ +0.09 (0.76%)
1 month | 3 months | 12 months
Get New Bayer Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for BAYRY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for BAYRY

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
▼ -100.00% Downside Potential
This price target is based on 13 analysts offering 12 month price targets for Bayer in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $11.98.
Hold
The current consensus among 13 investment analysts is to hold stock in Bayer.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 1 sell ratings
5/8/2019
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 1 sell ratings
8/6/2019
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 1 sell ratings
11/4/2019
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 1 sell ratings
2/2/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/2/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 0 sell ratings
7/31/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 5 hold ratings
  • 0 sell ratings
9/29/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 7 hold ratings
  • 1 sell ratings
10/29/2020

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 7 hold ratings
  • 1 sell ratings

DateBrokerageActionRatingPrice TargetDetails
10/21/2020Morgan StanleyReiterated RatingOverweight
i
10/13/2020BarclaysDowngradeOverweight ➝ Equal Weight
i
10/5/2020UBS GroupReiterated RatingBuy
i
10/2/2020Deutsche Bank AktiengesellschaftReiterated RatingBuy
i
10/2/2020AlphaValueDowngradeBuy
i
10/1/2020Bryan, Garnier & CoDowngradeNeutral ➝ Sell
i
10/1/2020CitigroupDowngradeBuy ➝ Neutral
i
10/1/2020HSBCDowngradeBuy ➝ Hold
i
10/1/2020CommerzbankDowngradeBuy ➝ Hold
i
9/14/2020Morgan StanleyReiterated RatingOverweight
i
9/9/2020BMO Capital MarketsInitiated CoverageMarket Perform
i
9/3/2020Credit Suisse GroupInitiated CoverageNeutral
i
8/11/2020Deutsche Bank AktiengesellschaftReiterated RatingBuy
i
8/10/2020Morgan StanleyReiterated RatingOverweight
i
6/26/2020JPMorgan Chase & Co.Reiterated RatingNeutral
i
6/26/2020Deutsche Bank AktiengesellschaftReiterated RatingBuy
i
6/25/2020Morgan StanleyReiterated RatingOverweight
i
6/25/2020HSBCUpgradeHold ➝ Buy
i
6/16/2020CommerzbankUpgradeHold ➝ Buy
i
4/22/2020Morgan StanleyReiterated RatingOverweight
i
3/4/2020Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy
i
12/17/2019Berenberg BankUpgradeHold ➝ Buy
i
8/16/2019Bank of AmericaUpgradeNeutral ➝ Buy
i
4/1/2019Berenberg BankInitiated CoverageBuy ➝ Hold
i
3/31/2019Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold
i
3/28/2019Bryan, Garnier & CoDowngradeNeutral ➝ Sell
i
3/25/2019Bank of AmericaReiterated RatingBuy ➝ Neutral
i
1/2/2019JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral
i
Rating by Richard Vosser at JPMorgan Chase & Co.
9/20/2018CitigroupUpgradeNeutral ➝ Buy
i
8/21/2018Berenberg BankUpgradeHold ➝ Buy
i
8/15/2018Jefferies Financial GroupDowngradeBuy ➝ Hold
i
8/13/2018JPMorgan Chase & Co.Reiterated RatingBuy
i
Rating by Richard Vosser at JPMorgan Chase & Co.
5/17/2018DZ BankReiterated RatingBuy
i
9/25/2017BNP ParibasUpgradeNeutral ➝ Outperform
i
7/3/2017Berenberg BankDowngradeBuy ➝ Hold
i
2/24/2017Sanford C. BernsteinReiterated RatingOutperform
i
Rating by jonas oxgaard at Sanford C. Bernstein
1/4/2017JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight
i
12/19/2016Jefferies Financial GroupUpgradeHold ➝ Buy
i
12/7/2016UBS GroupUpgradeNeutral ➝ Buy
i
9/15/2016Sanford C. BernsteinReiterated RatingBuy
i
9/14/2016The Goldman Sachs GroupReiterated RatingBuy
i
8/25/2016CitigroupUpgradeNeutral ➝ Buy
i
5/26/2016Sanford C. BernsteinReiterated RatingOutperform
i
Rating by Jeremy Redenius at Sanford C. Bernstein
5/25/2016CommerzbankUpgradeHold ➝ Buy
i
5/25/2016Deutsche Bank AktiengesellschaftReiterated RatingBuy
i
5/25/2016DZ BankReiterated RatingBuy
i
5/24/2016CitigroupReiterated RatingNeutral
i
5/24/2016The Goldman Sachs GroupReiterated RatingBuy
i
5/24/2016JPMorgan Chase & Co.Reiterated RatingNeutral
i
5/19/2016DZ BankReiterated RatingBuy
i
5/14/2016Sanford C. BernsteinReiterated RatingBuy
i
5/5/2016JPMorgan Chase & Co.Reiterated RatingNeutral
i
4/28/2016DZ BankReiterated RatingNeutral
i
4/27/2016Credit Suisse GroupDowngradeOutperform ➝ Neutral
i
4/18/2016JPMorgan Chase & Co.Reiterated RatingNeutral
i
4/8/2016Nord/LBReiterated RatingBuy
i
4/7/2016Credit Suisse GroupReiterated RatingBuy
i
3/22/2016JPMorgan Chase & Co.Reiterated RatingNeutral
i
3/7/2016BarclaysUpgradeUnderweight ➝ Equal Weight
i
3/1/2016DZ BankReiterated RatingBuy
i
1/26/2016Nord/LBReiterated RatingNeutral
i
1/19/2016JPMorgan Chase & Co.Reiterated RatingNeutral
i
1/13/2016Credit Suisse GroupReiterated RatingBuy
i
1/5/2016JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral
i
12/8/2015DZ BankReiterated RatingBuy
i
12/2/2015CitigroupDowngradeBuy ➝ Neutral
i
12/2/2015Nord/LBReiterated RatingNeutral
i
11/19/2015DZ BankReiterated RatingBuy
i
11/18/2015Jefferies Financial GroupBoost Price TargetHold$130.00
i
(Data available from 10/30/2015 forward)
Bayer logo
Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, cosmetics, and self-care solutions in the dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, cold and cough, foot care, and sun protection categories. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The Animal Health segment develops and markets products and solutions for the prevention and treatment of disease in companion and farm animals to veterinarians. Bayer Aktiengesellschaft has a collaboration agreement with MD Anderson Cancer Center at the University of Texas to develop cancer treatments; and research collaboration agreements with Haplogen GmbH and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. The company distributes its products through wholesalers, pharmacies, supermarket and drugstore chains, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.
Read More

Today's Range

Now: $11.98
$11.79
$12.00

50 Day Range

MA: $14.45
$11.89
$16.94

52 Week Range

Now: $11.98
$11.79
$21.59

Volume

1,294,433 shs

Average Volume

630,775 shs

Market Capitalization

$44.69 billion

P/E Ratio

N/A

Dividend Yield

4.46%

Beta

1.15